Myelodysplastic Syndromes
📧 Sign up to get email alerts when something new happens for Myelodysplastic Syndromes.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-05-17Clinical Trial Update: Fludarabine, Busulfan, and Antilymphocyte Globulin Followed by Donor Stem Cell Transplant in Treating Older Patients With Hematological Cancer [Phase 2]
Phase 2 trial evaluating fludarabine, busulfan, and anti-lymphocyte globulin followed by donor stem cell transplant in older patients with h…
-
CLINICAL_TRIALS trial_result · 2011-05-13Clinical Trial Update: Liposomal Amphotericin B (Ambisome) Versus Oral Voriconazole for the Prevention of Invasive Fungal Infections [Phase 2]
Phase 2 trial comparing liposomal amphotericin B (Ambisome) to oral voriconazole for prevention of invasive fungal infections in patients wi…
-
CLINICAL_TRIALS trial_result · 2011-05-12Clinical Trial Update: Interleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic Cancer [Phase 2]
A Phase 2 trial evaluated the combination of interleukin-2 and interferon alfa in adults with metastatic cancer. The study encompassed multi…
-
CLINICAL_TRIALS trial_result · 2011-05-09Clinical Trial Update: 5-azacytidine Valproic Acid and ATRA in AML and High Risk MDS [Phase 2]
Phase 2 clinical trial evaluating the combination of 5-azacytidine, valproic acid, and all-trans retinoic acid in acute myeloid leukemia and…
-
CLINICAL_TRIALS withdrawal · 2011-04-28Clinical Trial Update: Creation of Bone Marrow Microenvironment for Treatment of Myelodysplastic Syndrome (MDS) in Conjunction With Allogeneic Stem Cell Transplantation [Phase 2]
The Phase 2 trial investigating the creation of a bone marrow microenvironment to treat myelodysplastic syndromes in conjunction with alloge…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-04-26Clinical Trial Update: Lenalidomide and Darbepoetin in Low-Intermediate Risk Myelodysplastic Syndrome (MDS) [Phase 2]
Phase 2 trial update of lenalidomide plus darbepoetin in patients with low-intermediate risk myelodysplastic syndromes. The study was termin…
-
CLINICAL_TRIALS trial_result · 2011-04-14Clinical Trial Update: Azacytidine With Valproic Acid Versus Ara-C in Acute Myeloid Leukemia (AML)/ Myelodysplastic Syndrome (MDS) Patients [Phase 2]
Phase 2 trial evaluating azacitidine with valproic acid versus cytarabine in patients with acute myeloid leukemia or myelodysplastic syndrom…
-
CLINICAL_TRIALS trial_result · 2011-04-12Clinical Trial Update: PR1 Vaccination in Myelodysplastic Syndrome (MDS) [Phase 2]
A Phase 2 trial of PR1 Vaccination for leukemia and myelodysplastic syndrome was terminated; results were posted in 2011.
-
CLINICAL_TRIALS withdrawal · 2011-04-08Clinical Trial Update: To Determine the Role of Adding Campath-1H or ATG Given In-vivo in Addition to Fludarabine and Low Dose Busulfex on Outcome in Patients Treated With Reduced Intensity Conditioning [Phase 3]
A Phase 3 clinical trial evaluating adding Campath-1H (alemtuzumab) or ATG to fludarabine and low-dose busulfan conditioning for acute myelo…
-
CLINICAL_TRIALS trial_result · 2011-04-08Clinical Trial Update: Assessment of Labile Plasma Iron (LPI) in Myelodysplastic Syndromes (MDS) and Primary Myelofibrosis
This clinical trial update assesses labile plasma iron (LPI) in patients with myelodysplastic syndromes and primary myelofibrosis; the curre…
-
CLINICAL_TRIALS trial_result · 2011-04-05Clinical Trial Update: Determination of Safe and Effective Dose of Romiplostim (AMG 531) in Subjects With Myelodysplastic Syndrome (MDS)Receiving Hypomethylating Agents [Phase 2]
Phase 2 trial assessing the safe and effective dose of romiplostim in patients with myelodysplastic syndrome receiving hypomethylating agent…
-
CLINICAL_TRIALS trial_result · 2011-03-28Clinical Trial Update: Combination Chemotherapy in Treating Patients With Advanced Cancer [Phase 1]
A Phase 1 trial update reports results of a combination chemotherapy regimen in patients with advanced cancer, spanning several hematologic …
-
CLINICAL_TRIALS trial_result · 2011-03-17Clinical Trial Update: Lenalidomide Versus Placebo in Myelodysplastic Syndromes With a Deletion 5q[31] Abnormality [Phase 3]
A Phase 3 trial comparing lenalidomide to placebo in myelodysplastic syndromes with a deletion 5q abnormality has completed and posted resul…
-
CLINICAL_TRIALS trial_result · 2011-03-17Clinical Trial Update: A Study Evaluating Epoetin Alfa 40,000 IU (International Units) Every Week or 80,000 IU Every Week Compared to Placebo in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes at Risk for Transfusion [Phase 3]
A Phase 3 trial evaluating weekly epoetin alfa at two doses versus placebo in patients with low or intermediate-1 risk myelodysplastic syndr…
-
CLINICAL_TRIALS trial_result · 2011-03-10Clinical Trial Update: A Study of All-Trans Retinoic Acid (ATRA) and Bryostatin in Patients With Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) [Phase 2]
Phase 2 study evaluating all-trans retinoic acid and bryostatin in patients with acute myeloid leukemia and myelodysplastic syndromes has co…
-
CLINICAL_TRIALS trial_result · 2011-03-10Clinical Trial Update: Study of Vaccination With Autologous Acute Myeloblastic Leukemia Cells in Patients With Advanced Myelodysplasia or Acute Myelogenous Leukemia [Phase 1]
Phase 1 clinical trial evaluating vaccination with autologous acute myeloid leukemia cells in adults with advanced myelodysplastic syndromes…
-
CLINICAL_TRIALS trial_result · 2011-03-07Clinical Trial Update: Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer [Phase 2]
Phase 2 clinical trial evaluating chemotherapy, radiation therapy, and umbilical cord blood transplantation in patients with hematologic can…
-
CLINICAL_TRIALS trial_result · 2011-03-07Clinical Trial Update: Donor Umbilical Cord Blood Transplantation in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders [Phase 2]
Completed Phase 2 study evaluating donor umbilical cord blood transplantation for patients with leukemia, lymphoma, and certain nonmalignant…
-
CLINICAL_TRIALS research · 2011-03-07Clinical Trial Update: Immunologic Diagnostic Blood Test in Predicting Side-Effects in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Other Diseases
This update notes termination of a clinical trial evaluating an immunologic diagnostic blood test intended to predict donor stem cell transp…
-
CLINICAL_TRIALS trial_result · 2011-03-07Clinical Trial Update: Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Other Hematologic or Metabolic Diseases [Phase 2]
A Phase 2 clinical trial evaluating umbilical cord blood transplantation for hematologic cancers and related diseases has been completed.
-
CLINICAL_TRIALS trial_result · 2011-02-21Clinical Trial Update: Low-Dose Decitabine in Myelodysplastic Syndrome Post Azacytidine Failure [Phase 2]
Phase 2 trial evaluating low-dose decitabine in myelodysplastic syndromes after azacitidine failure; the study was terminated with results p…
-
CLINICAL_TRIALS trial_result · 2011-02-11Clinical Trial Update: Treosulfan and Fludarabine in Treating Younger Patients Who Are Undergoing a Donor Stem Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome [Phase 1, Phase 2]
Phase 1/2 trial evaluating treosulfan with fludarabine as conditioning before donor stem cell transplant in younger patients with AML, ALL, …
-
CLINICAL_TRIALS research · 2011-02-08Clinical Trial Update: Collection of Biological Data With Potential Prognostic Relevance in Patients With MYELODYSPLASTIC SYNDROMES
Clinical trial update focusing on collecting biological data with potential prognostic relevance in patients with myelodysplastic syndromes.
-
CLINICAL_TRIALS trial_result · 2010-12-22Clinical Trial Update: A Safety and Efficacy Study to Evaluate AMG 531 Treatment in Subject With Myelodysplastic Syndrome Receiving Revlimid [Phase 2]
Phase 2 safety and efficacy study of romiplostim (AMG 531) in patients with myelodysplastic syndromes receiving Revlimid. Results were poste…
-
CLINICAL_TRIALS research · 2010-12-07Clinical Trial Update: Cyclophosphamide, Fludarabine and Antithymocyte Globulin Conditioning in Myelodysplastic Syndrome (MDS)
This clinical trial update describes a conditioning regimen with cyclophosphamide, fludarabine, and antithymocyte globulin for myelodysplast…